Reveleer, a health tech company focused on value-based care, has unveiled two new suites of solutions for risk-bearing providers.
Reveleer helps payers manage risk adjustment and quality improvement in-house, using machine learning to simplify the process of collecting member data and improving outcomes. The Prospective Risk Adjustment and Quality Improvement product suites are designed to ease providers’ administrative burden and deliver timely clinical insights at the point of care.
“We give payers and risk-bearing providers a unique 360-degree view of member risk," Jay Ackerman, CEO of Reveleer, said in a press release. "We use proprietary AI to synthesize data from rich claims and clinical sources and quickly deliver accurate, actionable insights directly to clinicians as they care for patients. This represents a significant paradigm shift for value-based care."
Clinicians agree with the clinical recommendations more than 70% of the time, according to the company.
The Reveleer platform aggregates structured and unstructured patient data from more than 45 EHRs, 75 national and regional health information exchanges (HIEs) and community providers, specialists, labs, prescriptions and more. Its patient summary synthesizes and prioritizes suspected diagnoses with links to clinical source documentation to inform clinical decisions, risk assessment and quality review.
Meanwhile, the AI-driven clinical assisted documentation tool aims to help doctors document patient encounters quickly and accurately, leveraging a content library with more than 1.3 million synonyms, acronyms and abbreviations mapped to industry standards. Clinicians can document assessments and care plans to improve downstream data accuracy and reduce admin burden.
To date, Reveleer’s products have been focused on retrospective programs, or what happened to a patient after an encounter. But that usefulness is limited, Ackerman told Fierce Healthcare. The latest offerings are prospective, focused on insights at the point of care.
Reveleer first started selling to providers in 2022. Now, with improved AI and better access to HEI and EHR data, it can provide more robust product suites, Ackerman said.
Because the offerings are API-driven, they can be integrated into existing provider tools, such as population health management systems. The insights can be delivered within an EHR or in a printable format for those who prefer paper.
Reveleer works with more than 70 payers and large risk-bearing provider groups. The latest products have been deployed to 10 so far. All are in value-based arrangements. Reveleer’s goal is to help providers stay on top of evolving documentation requirements so they can be paid properly.
“The rules of the road are changing all the time,” Ackerman said. “Providers want to be focused on improving the health and well-being of their patients. They’re less focused on how they get judged and how they get paid.”
Reveleer has doubled its business in a year, Ackerman said, with a lot of its success attributable to AI. The company is considering how to use generative AI and large language models, whether publicly available or proprietary, to maximize their data. It is actively cultivating data sets to train its models. Reveleer expects to ingest 150 million pages of clinical data this year alone.